UNTREATED FOLLICULAR LYMPHOMA

Clinical trials for UNTREATED FOLLICULAR LYMPHOMA explained in plain language.

Never miss a new study

Get alerted when new UNTREATED FOLLICULAR LYMPHOMA trials appear

Sign up with your email to follow new studies for UNTREATED FOLLICULAR LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Major trial tests potential Game-Changer for common blood cancer

Disease control Recruiting now

This large, global study is testing whether a new drug called surovatamig (AZD0486), when combined with the existing drug rituximab, works better and is safer than standard chemotherapy plus rituximab for people newly diagnosed with follicular lymphoma, a type of slow-growing blo…

Matched conditions: UNTREATED FOLLICULAR LYMPHOMA

Phase: PHASE3 • Sponsor: AstraZeneca • Aim: Disease control

Last updated Mar 30, 2026 14:34 UTC

UNTREATED FOLLICULAR LYMPHOMA

Get alerted when new UNTREATED FOLLICULAR LYMPHOMA trials appear

Major trial tests potential Game-Changer for common blood cancer